Neuraly develops new drugs aimed at treating neurodegenerative diseases such as Alzheimer’s and Parkinson’s.

Neuraly

Neuraly Inc. | 1,217 followers on LinkedIn. We discover and develop revolutionary treatments for neurodegenerative diseases | Neuraly is a clinical-stage company whose mission is to discover and develop scientific discoveries in neurology into revolutionary new drugs that can radically improve and prolong the lives of people suffering from the devastating consequences of diseases such as Parkinson’s disease (PD), Alzheimer’s disease (AD) and other neurodegenerative disorders. The company is leveraging a deep understanding of the role of glia biology in neuroinflammation and neuroprotection in advancing a risk-diversified product portfolio for PD and AD.

Co-founder and Chief Scientific Officer at Neuraly

Viktor Roschke

Exec. Director, Bioanalytical Development at Neuraly, Inc.

Svetlana Sosnovtseva

Founder and CEO at D&D Pharmatech

Seulki Lee

R&D Program Manager at Neuraly Inc

Taylor Lee

Neuraly Inc.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 9, 2024 10:01 PM	cac2e540
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 9, 2024 10:01 PM	45e461e3
crunchbase trigger	general	Nov 9, 2024 10:01 PM	a5e6cef3
crunchbase profile	general
li profile	general	Nov 9, 2024 10:01 PM	890c79d5
translate crunchbase fundingrounds	general
peers	general	Nov 9, 2024 10:01 PM	4f51949e
news basic	general	Nov 9, 2024 10:01 PM	1111a710
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

NEUR

COM:NEURALYMED

Neuraly